Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 48

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 48
---
 Company’s
securities to The Nasdaq Capital Market.

On November 21, 2024, the
Company received a notice from the Staff of Nasdaq notifying the Company that its securities are subject to delisting due to the MVPHS
Deficiency and MLVS Deficiency. The Company requested a hearing to appeal the delisting determination before the Nasdaq Hearings Panel
(the “Panel”) on November 27, 2024. On November 29, 2024, the Company received a formal notice from Nasdaq that the Panel
will consider its appeal at an oral hearing on January 28, 2025 (the “Hearing”). On February 19, 2025, the Company
received written decision from the Panel, which granted an extension, allowing the Company additional time to regain compliance with the
Nasdaq Stock Market’s (“Nasdaq” or the “Exchange”) continued listing requirements, subject to meeting specific
compliance criteria within designated timeframes. On February 11, 2025, the Company carried out a 1-for-20 reverse stock split of its
issued and unissued shares. The effect of the reverse stock split was to consolidate every 20 issued and unissued share into one share.
On February 27, 2025, the Company received a notification letter from Nasdaq, indicating that the closing bid price of the Company’s
securities had been at $1.00 per share or greater for 10 consecutive business days from February 11, 2025 to February 26, 2025, and the
Company had regained compliance with the Minimum Bid Price Rule. In addition, on February 27, 2025, the Company received a confirmation
from Nasdaq that its application to transfer its listing to the Nasdaq Capital Market had been approved and that the Company’s securities
would be transferred to the Nasdaq Capital Market at the opening of business on February 28, 2025. On March 10, 2025, the Company received
a confirmation letter from Nasdaq confirming that it has demonstrated compliance with all of Nasdaq’s listing requirements, as required
in the Panel’s decision letter dated February 19, 2025.

<div align='center'>27</div>

If we are unable to achieve
and maintain compliance with such listing standards or other Nasdaq listing requirements in the future, our Class A Ordinary Shares could
be delisted from Nasdaq. A delisting of our Class A Ordinary Shares and